middl
east
respiratori
syndrom
coronaviru
merscov
major
emerg
zoonot
infecti
diseas
sinc
first
outbreak
viru
repeatedli
transmit
camel
human
confirm
case
caus
death
date
efficaci
drug
vaccin
biorxiv
preprint
merscov
increas
potenti
caus
public
health
emerg
critic
step
life
cycl
merscov
fusion
host
cell
spike
protein
main
determin
viral
entri
proteolyt
cleavag
expos
fusion
peptid
fp
initi
membran
fusion
previou
studi
relat
sever
acut
respiratori
syndrom
coronaviru
sarscov
fp
shown
calcium
ca
play
import
role
fusogen
activ
via
ca
bind
pocket
conserv
glutam
acid
e
aspart
acid
residu
sarscov
merscov
fp
share
high
sequenc
homolog
investig
whether
ca
requir
merscov
fusion
substitut
e
residu
merscov
fp
neutral
charg
alanin
upon
verifi
mutant
cell
surfac
express
proteolyt
cleavag
test
mutant
abil
mediat
infect
pseudoparticl
pp
host
cell
without
ca
result
demonstr
intracellular
ca
enhanc
merscov
wt
pp
infect
approxim
twofold
crucial
residu
ca
interact
electron
spin
reson
reveal
enhanc
could
attribut
ca
increas
merscov
fp
fusionrelev
membran
order
intriguingli
isotherm
calorimetri
titrat
show
merscov
fp
bind
one
ca
oppos
sarscov
fp
bind
two
data
suggest
signific
differ
fpca
interact
merscov
sarscov
fp
despit
high
sequenc
similar
number
ca
ion
interact
fp
implic
fusion
dynam
viru
dromedari
camel
current
believ
diseas
outbreak
human
result
interact
dromedari
camel
although
transmiss
human
rare
rout
respons
widespread
outbreak
merscov
south
korea
moreov
demonstr
merslik
bat
cov
could
potenti
infect
human
tissu
absenc
intermedi
host
respect
tissu
express
proteas
abl
prime
viru
fusion
recent
world
health
organ
list
merscov
one
ten
diseas
requir
urgent
acceler
research
develop
potenti
caus
public
health
emerg
efficaci
drug
andor
vaccin
counter
address
need
import
nuanc
understand
merscov
infect
process
develop
therapeut
target
crucial
step
merscov
infect
merscov
spike
protein
contain
receptor
bind
subunit
membran
fusion
subunit
facilit
bind
host
cell
surfac
receptor
dipeptidyl
peptidas
fusion
host
cell
membran
respect
mediat
fusion
host
cell
membran
need
cleav
either
host
cell
surfac
proteas
endosom
proteas
transmembran
proteas
serin
furin
cathepsin
cleavag
occur
two
differ
site
boundari
adjac
fusion
peptid
fp
within
domain
suggest
cleavag
event
act
concert
promot
membran
fusion
viral
infect
first
cleavag
event
take
place
site
believ
open
site
proteolyt
process
result
exposur
fp
consequ
fp
insert
host
membran
mediat
membran
fusion
merscov
viral
fusion
occur
two
differ
locat
host
cell
plasma
membran
endosom
membran
host
cell
surfac
proteas
cleav
merscov
entri
directli
plasma
membran
absenc
cell
surfac
proteas
merscov
endocytos
coronavirus
cov
compris
famili
envelop
virus
caus
respiratori
andor
enter
tract
infect
across
varieti
host
recent
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
first
isol
man
kingdom
saudi
arabia
highlight
pathogen
potenti
cov
date
merscov
caus
laboratoryconfirm
human
infect
worldwid
result
death
casefat
howev
human
merscov
origin
bat
transit
intermedi
host
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
endosom
proteas
cathepsin
cleav
endosom
entri
howev
contrast
virus
influenza
merscov
fusion
seem
depend
ph
chang
endosom
receptor
bind
conjunct
proteolyt
activ
suffici
trigger
fusion
thorough
descript
fusion
pathway
summar
sever
excel
review
recent
studi
fp
sever
acut
respiratori
syndrom
coronaviru
sarscov
suggest
fp
region
begin
immedi
downstream
cleavag
site
separ
two
distinct
domain
author
show
increas
membran
order
propos
togeth
form
extend
fp
act
bipartit
fusion
platform
intriguingli
fp
subdomain
requir
calcium
cation
ca
exert
function
membran
entri
fusion
propos
neg
charg
aspart
acid
glutam
acid
e
residu
coordin
posit
charg
ca
within
fusion
platform
promot
greater
membran
order
furthermor
author
show
deplet
extracellular
well
intracellular
ca
pool
result
significantli
reduc
infect
sarscov
pseudoparticl
suggest
plasma
membran
endosom
cell
entri
pathway
regul
ca
studi
reveal
import
role
ca
fusion
dynam
envelop
virus
rubella
viru
ruv
exampl
requir
ca
viru
entri
infect
ca
coordin
two
fusion
loop
ruv
fusion
protein
asparagin
n
aspart
acid
residu
shown
essenti
viru
viabil
recent
ca
report
enhanc
entri
ebola
viru
ebov
directli
interact
fp
ebola
viru
fusion
protein
author
abl
identifi
two
neg
charg
residu
fp
interact
ca
interact
critic
viral
fusion
host
cell
address
question
whether
ca
requir
viral
entri
infect
merscov
creat
set
protein
mutant
neg
charg
residu
fp
mutat
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
alanin
use
differ
mutant
pseudoparticl
infect
assay
demonstr
fusion
merscov
promot
depend
ca
biophys
analysi
demonstr
ca
interact
merscov
increas
membran
order
ca
depend
manner
data
suggest
singl
glutam
acid
residu
region
complementari
sarscov
domain
involv
ca
coordin
order
test
ca
requir
residu
within
merscov
fp
necessari
coordin
gener
set
mutat
protein
substitut
neg
charg
aspart
acid
glutam
acid
residu
fp
alanin
figur
defin
fp
region
base
sequenc
comparison
sarscov
fp
describ
previous
figur
mutant
plasmid
gener
via
sitedirect
mutagenesi
verifi
sequenc
data
shown
next
test
whether
mutat
protein
express
transfect
plasmid
dna
hek
cell
sinc
merscov
protein
cleav
constitut
express
proteas
matur
process
ad
proteas
inhibitor
decrvkrcmk
immedi
transfect
block
cleavag
figur
decrvkrcmk
shown
inhibit
wide
varieti
proteas
furin
cathepsin
trypsin
block
cleavag
want
confirm
mutant
protein
properli
express
traffick
cell
membran
surfac
like
wt
protein
isol
protein
h
post
transfect
via
cellsurfac
biotinyl
western
blot
analysi
cell
surfac
protein
show
mutant
protein
express
similar
level
merscov
wt
protein
figur
mutant
protein
express
next
want
investig
whether
mutant
exhibit
cleavag
pattern
wt
sinc
proteolyt
cleavag
import
crucial
trigger
viral
fusion
accomplish
treat
transfect
cell
trypsin
prior
protein
isol
western
blot
analysi
reveal
cleavag
pattern
mutat
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
protein
similar
wt
suggest
introduc
mutat
fp
impair
proteas
access
cleavag
figur
establish
mutat
version
merscov
protein
express
exhibit
similar
cleavag
pattern
wt
initi
screen
whether
differ
mutant
protein
compromis
abil
induc
cellcel
fusion
therefor
coexpress
protein
togeth
merscov
receptor
vero
cell
h
visual
syncytia
format
use
immunofluoresc
assay
ifa
trypsin
treatment
transfect
cell
requir
cell
nativ
express
proteas
cleav
wt
mutat
protein
cellcel
fusion
control
ad
proteas
inhibitor
decrvkrcmk
cell
express
wt
prevent
cleavag
block
merscov
entri
analyz
cell
fluoresc
microscopi
quantifi
cellcel
fusion
count
number
nuclei
per
syncytium
cell
express
wt
exhibit
strong
syncytia
format
multipl
nuclei
addit
decrvkrcmk
control
effici
prevent
cellcel
fusion
figur
b
strikingli
absenc
inhibitor
mutant
impair
abil
trigger
cellcel
fusion
extent
cell
treat
decrvkrcmk
figur
b
howev
sinc
cell
express
form
syncytia
similar
cell
express
wt
suggest
critic
residu
fusogen
activ
merscov
respons
mutant
inabl
mediat
cellcel
fusion
test
mutant
show
attenu
cellcel
fusion
variou
degre
howev
none
mutant
found
defect
protein
mediat
cellcel
fusion
figur
b
cellcel
fusion
result
strongli
suggest
import
residu
fusogen
activ
merscov
except
data
obtain
mutant
indic
may
play
minor
role
trigger
fusion
howev
mechan
cellcel
fusion
viruscel
fusion
may
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
significantli
differ
factor
membran
curvatur
andor
densiti
viral
protein
may
impact
viruscel
fusion
differ
cellcel
fusion
henc
cellcel
fusion
result
provid
indic
role
individu
e
residu
fp
region
need
verifi
viral
infect
host
cell
merscov
risk
group
agent
need
handl
biosafeti
level
set
employ
viral
pseudotyp
techniqu
gener
pseudoparticl
pp
serv
surrog
nativ
virion
suitabl
infect
set
pseudoparticl
consist
murin
leukemia
viru
mlv
core
decor
respect
glycoprotein
recapitul
entri
step
bind
fusion
nativ
viru
furthermor
pp
carri
genom
encod
luciferas
upon
success
infect
cell
luciferas
report
integr
host
cell
genom
drive
luciferas
product
within
cell
use
quantifi
degre
infect
gener
pp
carri
mutant
protein
infect
cell
permiss
cell
line
merscov
infect
high
express
h
cell
lyse
briefli
incub
luciferin
substrat
oxid
cellular
luciferas
produc
luminesc
measur
rel
luminesc
valu
provid
quantit
readout
infect
mutant
protein
mediat
infect
ensur
infect
pp
carri
differ
protein
variant
compar
perform
western
blot
analysi
detect
amount
incorpor
pp
figur
cell
treat
proteas
inhibitor
decrvkrcmk
protein
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
full
length
cleav
protein
variant
continu
analyz
infect
pp
carri
mutat
protein
agreement
ifa
observ
pp
exhibit
fivefold
reduct
infect
compar
wt
pp
pp
significantli
differ
wt
pp
figur
addit
also
observ
infect
pp
carri
significantli
lower
wt
pp
howev
infect
restor
doubl
mutant
figur
suggest
residu
critic
fusion
residu
crucial
fusion
would
expect
doubl
mutant
display
impair
infect
well
none
test
mutant
exhibit
signific
differ
compar
infect
wt
pp
figur
seem
exhibit
enhanc
infect
compar
wt
find
statist
signific
figur
sarscov
previous
shown
depend
extracellular
intracellular
ca
pool
success
infect
believ
depend
due
ca
interact
sarscov
fp
high
sequenc
similar
sarscov
merscov
fp
figur
interest
determin
extracellular
andor
intracellular
ca
also
play
role
merscov
fusion
analysi
neg
charg
residu
merscov
fp
region
thu
far
suggest
crucial
residu
viral
fusion
perhap
coordin
ca
interest
observ
fusion
behavior
mutant
would
differ
wt
vari
calcium
concentr
environ
thu
focus
wt
protein
carri
amino
acid
substitut
although
express
decreas
infect
proceed
reason
previous
mention
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
activ
intracellularli
significantli
impact
cell
viabil
concentr
chelat
intracellular
ca
result
twofold
drop
infect
merscov
wt
pp
figur
infect
also
reduc
mutant
howev
detect
signific
reduct
infect
doubl
mutant
deplet
intracellular
ca
next
test
impact
extracellular
ca
merscov
fusion
host
cell
membran
incub
cell
ethylen
glycolbi
ether
n
n
n
ntetraacet
acid
egta
prior
infect
infect
merscov
wt
pp
reduc
extracellular
ca
deplet
figur
differ
infect
pp
carri
mutat
protein
result
describ
suggest
ca
promot
entri
merscov
host
cell
greater
depend
intracellular
ca
concentr
extracellular
ca
concentr
sinc
hypothes
critic
residu
ca
coordin
would
expect
knockout
variant
infect
level
independ
ca
concentr
howev
intracellular
ca
studi
show
singl
mutant
impact
ca
possibl
explan
appar
contradict
could
due
fp
flexibl
perhap
avail
ca
bind
adjac
compens
maintain
ca
coordin
fp
support
explan
infect
doubl
mutant
ca
independ
possibl
residu
mediat
ca
interact
knock
thu
believ
mediat
ca
bind
merscov
region
howev
previou
studi
ruv
ebov
show
two
distinct
oppos
residu
fp
region
requir
coordin
ca
proceed
determin
residu
ca
coordin
merscov
fp
model
suggest
two
possibl
residu
region
ca
coordin
togeth
name
figur
therefor
creat
merscov
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
protein
carri
substitut
confirm
three
mutat
protein
express
traffick
plasma
membran
cell
protein
extract
cellsurfac
biotinyl
figur
ifa
result
show
cell
express
impair
abil
form
syncytia
similar
extent
cell
express
wt
treat
decrvkrcmk
singl
mutant
figur
b
howev
assess
protein
incorpor
pp
found
wt
pp
carri
similar
amount
protein
protein
incorpor
pp
significantli
reduc
figur
cell
infect
pp
equip
mutat
found
infect
similar
singl
mutant
figur
infect
howev
significantli
lower
compar
pp
carri
protein
infecti
find
consist
result
pp
western
blot
analysi
sinc
incorpor
significantli
less
protein
like
result
reduc
entri
deplet
intracellular
ca
level
use
baptaam
chang
infect
test
pp
carri
differ
amino
acid
substitut
figur
chelat
extracellular
ca
use
egta
infect
also
alter
mutant
figur
summari
mutant
analysi
identifi
second
bind
partner
ca
inconclus
data
suggest
like
second
bind
partner
infect
similar
singl
mutant
howev
due
poor
incorpor
mutant
pp
abl
compar
infect
wt
singl
mutant
higher
amount
protein
use
electron
spin
reson
esr
examin
effect
merscov
fp
membran
test
whether
membran
fusion
peptid
requir
ca
techniqu
spin
label
incorpor
lipid
variou
posit
act
depth
probe
multilamellar
vesicl
mlv
contain
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
dipalmitoylphosphatidyltempocholin
dpptc
spin
label
head
region
wherea
phosphocholin
label
either
upper
tail
region
lower
tail
region
order
paramet
indic
amount
membran
order
given
depth
serv
readout
fp
membran
penetr
depth
chang
membran
order
may
reduc
energi
barrier
two
membran
thu
promot
fusion
previous
studi
fp
differ
virus
induc
membran
order
illustr
sshape
curv
function
increas
fp
lipid
pl
ratio
nonfunct
fp
random
peptid
membraneord
effect
produc
scrambl
signal
therefor
examin
membran
order
effect
peptid
allow
determin
whether
fp
shown
figur
b
merscov
fp
induc
greatest
order
effect
head
dpptc
uppertail
region
mm
ca
test
deep
hydrophob
region
membran
order
observ
data
shown
ca
supplement
trace
ca
chelat
mm
egta
time
order
effect
measur
indic
function
merscov
fp
ca
depend
compar
sarscov
fp
howev
merscov
fp
weaker
effect
dpptc
case
maxim
merscov
fp
smaller
approx
sarscov
fp
approx
highest
pl
ratio
experi
fit
sshape
curv
use
four
paramet
logist
equat
min
min
p
builtin
function
origin
originlab
pl
ratio
x
induc
half
maxim
membran
order
chang
min
p
hill
slope
hill
slope
indic
cooper
ligandreceptor
bind
reaction
sarscov
fp
merscov
fp
indic
merscov
fp
less
effect
sarscov
fp
hill
slope
sarscov
fp
merscov
fp
indic
sarscov
fp
induc
membran
order
cooper
fashion
merscov
fp
mm
ca
scrambl
peptid
show
effect
membran
order
although
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
scrambl
control
peptid
base
sarscov
fp
sequenc
use
control
merscov
fp
high
sequenc
similar
merscov
sarscov
fp
figur
test
effect
ca
vari
ca
concentr
fix
pl
ratio
effect
order
caus
ca
interact
liposom
rather
fusion
peptid
remov
subtract
liposom
ca
peptid
mixtur
measur
three
compon
liposom
peptid
ca
present
yield
method
prove
solid
approach
singl
effect
fp
influenc
ca
complex
membranepeptideca
system
shown
indic
ca
ion
bind
sarscov
fp
cooper
merscov
fp
sarscov
fp
case
explan
cooper
sarscov
fp
two
ca
bind
site
bind
ca
ion
one
site
stabil
secondari
structur
help
bind
anoth
ca
ion
site
lack
cooper
case
merscov
fp
suggest
may
one
bind
site
directli
investig
interact
ca
merscov
fp
use
isotherm
titrat
calorimetri
itc
experi
synthet
merscov
fp
ad
reaction
cell
neutral
buffer
condit
ph
ml
ph
titrat
cell
dropwis
heat
flow
gener
reaction
record
reaction
heat
inject
calcul
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
integr
heat
flow
time
subtract
dilut
heat
measur
titrat
ml
ph
buffer
reaction
heat
ca
fp
inject
vs
molar
ratio
ca
fp
plot
shown
figur
reaction
heat
posit
indic
reaction
endotherm
reaction
heat
decreas
titrat
indic
fp
satur
ca
ion
toward
end
titrat
reason
endotherm
reaction
may
due
na
ion
interact
fp
replac
ca
ion
endotherm
reaction
also
observ
inject
sar
cov
fp
similar
experiment
setup
fit
data
onesit
model
assum
bind
site
bind
affin
calcul
bind
constant
reaction
enthalpi
kcalmol
bind
stoichiometri
ca
fp
stoichiometri
ca
merscov
fp
significantli
differ
sarscov
fp
similar
sarscov
fp
respect
result
strongli
support
hypothesi
merscov
fp
bind
one
ca
ion
sarscov
fp
bind
two
one
one
weaker
ca
bind
energi
merscov
fp
also
consist
esr
result
show
merscov
fp
induc
maxim
membran
order
effect
higher
ca
concentr
sarscov
fp
viral
entri
host
cell
one
critic
step
life
cycl
viru
envelop
virus
merscov
sarscov
util
class
fusion
protein
facilit
bind
fusion
host
cell
membran
central
factor
allow
viral
host
membran
merg
fp
within
protein
expos
upon
proteolyt
cleavag
recent
report
demonstr
crucial
role
ca
viral
fusion
coordin
neg
charg
residu
e
within
fp
show
ca
promot
viral
entri
merscov
host
cell
investig
residu
seem
major
residu
ca
bind
substitut
dramat
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
decreas
viral
infect
figur
believ
howev
due
flexibl
fp
adjac
residu
compens
loss
observ
attenu
infect
deplet
intracellular
ca
level
restor
mutant
figur
shorter
side
chain
posit
may
establish
bond
ca
strong
e
therefor
restor
infect
minim
attempt
identifi
bind
partner
gener
doubl
mutant
neighbor
residu
success
observ
poor
protein
incorpor
pp
intrigu
western
blot
cellcel
fusion
result
show
mutant
properli
express
traffick
cell
membran
poorli
integr
virion
surrog
one
possibl
explan
mutat
impact
integr
fp
domain
manner
hinder
virion
incorpor
role
ca
viral
fusion
explor
envelop
virus
ruv
sarscov
ebov
human
immunodefici
viru
type
influenza
seem
signific
differ
regard
role
ca
mediat
viral
host
cell
membran
fusion
studi
show
ca
bind
fp
influenza
fusion
event
prior
observ
influenza
fusion
protein
show
increas
membran
interact
presenc
ca
indic
ca
act
blanket
promot
viral
fp
insert
target
membran
case
hiv
lead
structur
chang
fp
form
absenc
ca
chang
conform
antiparallel
structur
presenc
ca
howev
import
note
ca
enhanc
fusion
abovement
virus
attenu
absenc
abrog
contrast
ca
directli
interact
fp
ruv
sarscov
ebov
deplet
ca
result
incap
viru
fuse
host
cell
ruv
ebov
key
residu
within
fp
identifi
coordin
ca
concert
low
ph
result
conform
chang
fp
subsequ
fusion
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
demonstr
merscov
fp
similar
interact
ca
sarscov
fp
distinct
differ
data
show
ca
significantli
promot
merscov
fusion
fusion
absenc
ca
attenu
complet
abrog
could
due
fact
merscov
fp
bind
one
ca
ion
discuss
greater
detail
opposit
host
cell
entri
sarscov
bind
two
ca
fp
region
entir
abrog
deplet
intracellular
ca
level
given
high
sequenc
similar
fp
region
two
virus
find
implic
stoichiometri
fp
ca
signific
impact
fusion
dynam
viru
ca
could
argu
fusion
merscov
regul
ca
membran
believ
rule
possibl
data
obtain
mutant
esr
itc
provid
good
evid
ca
interact
directli
merscov
fp
use
esr
demonstr
merscov
fp
also
exert
membran
order
effect
similar
observ
sarscov
fp
well
viral
fp
strengthen
hypothesi
membran
order
effect
requir
step
viral
entri
membran
order
effect
turn
serv
use
biophys
indic
examin
condit
requir
fp
activ
use
method
previous
demonstr
sarscov
ebov
fp
ca
depend
show
merscov
fp
ca
depend
howev
although
sshape
curv
merscov
fp
similar
sarscov
fp
merscov
fp
smaller
membran
order
effect
sarscov
fp
mm
ca
membran
order
effect
satur
higher
pl
ratio
merscov
fp
sarscov
fp
figur
keep
pl
ratio
constant
merscov
fp
also
satur
higher
concentr
ca
increas
half
maxim
around
mm
compar
around
mm
sarscov
fp
figur
result
suggest
merscov
fp
weaker
interact
ca
thu
requir
higher
ca
concentr
reach
maxim
activ
hypothesi
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
support
itc
experi
show
reaction
energi
ca
merscov
fp
weaker
sarscov
fp
itc
experi
also
demonstr
stoichiometri
ca
merscov
fp
close
one
differ
sarscov
case
sarscov
bind
two
ca
fp
region
one
interpret
indic
one
ca
interact
merscov
fp
thu
although
sequenc
sar
merscov
fp
similar
may
interact
ca
differ
believ
interact
occur
merscov
region
data
identifi
residu
region
interact
ca
suggest
domain
import
ca
bind
none
test
mutant
region
provid
clear
evid
ca
bind
occur
domain
differ
sarscov
fp
strike
despit
high
sequenc
similar
sarscov
merscov
fp
signific
differ
fp
ca
interact
esr
result
indic
order
effect
sequenc
specif
possibl
small
differ
sequenc
region
merscov
sarscov
respons
differ
ca
interact
show
sarscov
merscov
function
interact
ca
ion
appear
signific
posit
stoichiometr
differ
two
spike
protein
prior
mutagenesi
experi
carri
conserv
e
residu
sarscov
region
recognit
bipartit
natur
fp
prior
consider
potenti
ca
interact
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
unclear
overal
prior
studi
broad
agreement
interact
ca
merscov
compar
sarscov
biolog
scenario
possibl
explan
differ
might
ca
prime
fp
differ
step
host
cell
entri
process
sarscov
extracellular
ca
bind
domain
may
prepar
fusion
loop
subsequ
intracellular
ca
merscov
extracellular
ca
bind
step
may
requir
none
test
mutant
region
show
strike
reduct
infect
wherea
intracellular
ca
deplet
significantli
reduc
infect
futur
studi
design
explor
swap
differ
residu
entir
region
merscov
sarscov
fp
would
impact
membran
fusion
entri
pathway
calcium
interact
would
interest
see
merscov
adopt
sarscov
fusion
behavior
vice
versa
differ
cell
type
howev
could
also
affect
fusion
behavior
virus
previou
studi
explor
fusion
dynam
sarscov
merscov
pp
use
vero
cell
other
use
cell
studi
merscov
pp
infect
exhibit
higher
express
furin
seem
promot
entri
mainli
via
endocyt
rout
address
impact
cell
type
fusion
dynam
merscov
sarscov
complement
studi
fp
domain
two
virus
cell
obtain
american
type
cultur
collect
cell
obtain
japan
health
scienc
research
resourc
bank
cell
maintain
dulbecco
modifi
eagl
medium
dmem
cellgro
supplement
mm
hepe
cellgro
hyclon
fetalclon
ii
ge
cdmem
merscov
gene
codonoptim
mammalian
express
clone
invitrogen
describ
previous
pcmvmlv
gagpol
murin
leukemia
viru
mlv
packag
construct
ptgluc
transfer
vector
encod
luciferas
report
pcaggsvsvg
plasmid
describ
recombin
chloromethyl
keton
tpck
treat
trypsin
purchas
sigma
proteas
inhibitor
decrvkrcmk
obtain
tocri
calcium
chelat
baptaam
egta
purchas
tocri
vwr
respect
mutat
merscov
construct
gener
site
direct
mutagenesi
use
quikchang
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
vero
cell
grown
microscopi
chamber
slide
millipor
transfect
respect
construct
use
lipofectamin
invitrogen
transfect
perform
accord
manufactur
protocol
h
post
transfect
immunofluoresc
assay
carri
previous
describ
except
membran
permeabil
millet
pna
merscov
protein
detect
use
antibodi
describ
western
blot
analysi
quantif
imag
least
five
randomli
select
field
acquir
nuclei
nine
syncytia
condit
count
manual
calcul
averag
nucleisyncytia
averag
standard
deviat
calcul
use
microsoft
excel
graphpad
prism
data
visual
use
graphpad
prism
product
infect
pseudoparticl
pp
perform
previous
describ
minor
modif
brief
pp
individu
construct
produc
transfect
cell
respect
plasmid
dna
ptgluc
pcmvmlvgagpol
use
pei
describ
h
post
transfect
supernat
harvest
centrifug
x
g
minut
remov
cell
debri
filter
syring
filter
store
small
aliquot
infect
assay
cell
seed
plate
cell
wash
pb
pp
ad
incub
h
rock
h
cell
supplement
cdmem
medium
incub
h
cell
lyse
luciferas
activ
measur
use
luciferas
assay
kit
promega
read
perform
glomax
system
promega
experi
three
technic
replic
prepar
experi
repeat
least
three
time
data
analyz
use
graphpad
prism
chelat
extracellular
calcium
cell
preincub
ul
dmem
hyclon
mm
hepe
h
h
dmemwa
aspir
cell
infect
pp
contain
um
egta
h
rock
analysi
infect
cell
describ
neg
control
control
conduct
preincub
cell
dmem
infect
pp
without
treatment
western
blot
analysi
incorpor
protein
ml
harvest
pp
spun
x
g
h
supernat
aspir
protein
pellet
resuspend
laemmli
buffer
protein
load
sdspage
gel
western
blot
analysi
carri
describ
structur
merscov
protein
download
protein
data
bank
pdb
access
number
doi
http
model
perform
describ
previous
use
chimera
softwar
chimera
version
univers
california
imag
creat
use
adob
illustr
cc
lipid
popc
pop
chain
spin
label
head
group
spin
label
dipalmitoylphospatidyltempocholin
dpptc
purchas
avanti
polar
lipid
alabast
al
synthes
laboratori
accord
previou
protocol
cholesterol
purchas
sigma
correspond
shuffl
peptid
composit
membran
use
studi
consist
previou
studi
prepar
sampl
lipid
esr
studi
desir
amount
fp
mgml
ad
lipid
mlv
dispers
min
incub
dispers
spun
rpm
min
concentr
peptid
measur
use
uv
ensur
complet
bind
peptid
pellet
transfer
quartz
capillari
tube
esr
measur
esr
spectra
collect
elexsi
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
esr
spectromet
bruker
instrument
billerica
xband
ghz
use
temperatur
control
bruker
instrument
billerica
esr
spectra
label
lipid
analyz
use
nll
fit
program
base
stochast
liouvil
equat
use
momd
microscop
order
macroscop
disord
model
previou
studi
fit
strategi
describ
employ
budil
et
al
nll
fit
program
obtain
converg
optimum
paramet
gtensor
atensor
paramet
use
simul
determin
rigid
limit
spectra
order
tensor
paramet
extract
spectra
defin
follow
wigner
rotat
matrix
element
polar
azimuth
angl
orient
rotat
axe
nitroxid
bond
lipid
rel
director
bilay
ie
preferenti
orient
lipid
molecul
angular
bracket
impli
ensembl
averag
uncertainti
calcul
wellknown
fashion
definit
dimensionless
order
potenti
uncertainti
found
fit
typic
uncertainti
find
rang
uncertainti
repeat
experi
less
indic
strongli
chain
segment
nitroxid
attach
align
along
normal
lipid
bilay
strongli
correl
hydrationdehydr
lipid
bilay
budil
de
sanghyuk
l
saxena
freed
jh
nonlinearleastsquar
analysi
slowmot
epr
spectra
one
two
dimens
use
modifi
levenbergmarquardt
algorithm
j
magn
nuclei
syncytia
count
averag
number
nuclei
per
syncytia
calcul
error
bar
repres
standard
deviat
n
statist
analysi
perform
use
unpair
student
ttest
compar
wt
respect
mutant
p
p
p
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
pp
treat
mm
egta
calcium
chelat
infect
normal
wt
pp
infect
error
bar
repres
standard
deviat
n
statist
analysi
perform
use
unpair
student
ttest
indic
p
p
p
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
